Prescriber's Corner

Eribulin Mesylate: Unique Advancement in Metastatic Breast Cancer

Kelley D. Mayden, MSN, FNP, AOCNP®

From Southwest Virginia Cancer Center, Norton, Virginia

The author has no conflicts of interest to disclose.

Correspondence to: Kelley D. Mayden, MSN, FNP, AOCNP®, 671 Highway 58 East, Norton, VA 24273. E-mail: kdunrun@charter.net


J Adv Pract Oncol 2011;2:125–128 | DOI: 10.6004/jadpro.2011.2.2.7 | © 2011 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me